We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.
4d09
From Proteopedia
(Difference between revisions)
| Line 20: | Line 20: | ||
</div> | </div> | ||
<div class="pdbe-citations 4d09" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 4d09" style="background-color:#fffaf0;"></div> | ||
| - | |||
| - | ==See Also== | ||
| - | *[[Phosphodiesterase|Phosphodiesterase]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 12:34, 6 November 2017
PDE2a catalytic domain in complex with a brain penetrant inhibitor
| |||||||||||
Categories: 3',5'-cyclic-nucleotide phosphodiesterase | Andres, J I | Buijnsters, P | DeAngelis, M | Langlois, X | Rombouts, F | Sanderson, W | Trabanco, A | Tresadern, G | VanHoof, G | VanRoosbroeck, Y | Animal | Cyclic nucleotide phosphodiesterase | Disease model | Drug evaluation | Hydrolase | Phosphodiesterase 2 inhibitor | Phosphodiesterase inhibitor | Preclinical | Protein binding | Structure-activity relationship | Type 2 | Type 4
